Jacek Borawski

Jacek Borawski

Auto-generated profile, based on publicly available information

Jacek Borawski

Department of Nephrology and Transplantation with Dialysis Unit, Medical University, Bialystok, Poland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2006 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
JBJ. Borawski
J. Borawski
MNMagdalena Nowosielska
Magdalena Nowosielska
WSW. Stokowska
W. Stokowska
MMM. Mysliwiec
M. Mysliwiec
Background. After gastrointestinal infection with Shiga-like toxin (Stx) producing Escherichia coli, the toxin is transported from the intestine to the renal microvascular endothelium. This is the main target for Stx in humans. Previous studies indicated that polymorphonuclear leucocytes (PMN) could serve as carriers for Stx in the systemic circulation. As at a later stage we could not confirm these data, we performed new studies.


1 July 2001 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
JBJacek Borawski
Jacek Borawski
Beata NaumnikBeata Naumnik
Beata Naumnik
KPKrystyna Pawlak
Krystyna Pawlak
MMMichal Mysliwiec
Michal Mysliwiec
Background. Increased plasma soluble von Willebrand factor antigen (vWF : Ag) level, a marker of vascular endothelial cell dysfunction, is a strong predictor of atherosclerotic cardiovascular disease (CVD) in the general population. We studied cross‐sectional associations between vWF : Ag level, prevalence of CVD, and related factors including pre‐dialysis arterial blood pressure (BP) and some markers of inflammation in maintenance haemodialysis (HD) patients. Methods and results. Plasma vWF : Ag level measured by an enzyme‐linked immunosorbent assay (ELISA) was higher in 110 HD patients than in 20 controls. On bivariate regression analysis, vWF : Ag level was directly associated with the presence of CVD, age, fibrinogen and the use of enoxaparin (vs unfractionated heparin) during HD procedures, and inversely with albumin and pre‐dialysis BP. The patients with prevalent CVD were older, had higher vWF : Ag, white blood cell and platelet counts, fibrinogen and triglycerides, lower albumin levels, and were less frequently on combination antihypertensive therapy. Multivariable analyses identified low pre‐dialysis BP, hypoalbuminaemia and hyperfibrinogenaemia (in descending order of significance) as independent predictors of high vWF : Ag level. There were no associations between vWF : Ag levels and gender, ABO blood type, smoking, body mass index, renal failure cause, duration of HD therapy, Kt/V, normalized protein catabolic rate, dialysate buffers, dialysers, viral hepatitis, erythropoietin treatment, specific antihypertensive drugs, haemoglobin, white blood cell and platelet counts, liver enzymes, phosphorous, total cholesterol, and triglycerides. Conclusion. Elevated plasma levels of endothelial dysfunction marker vWF : Ag in maintenance HD patients are associated with established cardiovascular mortality risk factors such as low pre‐dialysis blood pressure and the activated acute phase response.

1 January 1995 in Thrombosis Research
Verified
Journal Article
Closed access
Jolanta MałyszkoJolanta Małyszko
Jolanta Małyszko
JBJ. Borawski
J. Borawski
ARA. Rydzewski
A. Rydzewski
MKM. Kalinowski
M. Kalinowski
AAA. Azzadin
A. Azzadin
WBW. Buczko
W. Buczko

1 July 2003 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
Beata NaumnikBeata Naumnik
Beata Naumnik
JBJacek Borawski
Jacek Borawski
MMMichał Myśliwiec
Michał Myśliwiec
Background. Heparin inhibits prothrombotic tissue factor (TF) and releases its inhibitor, tissue factor pathway inhibitor (TFPI), from the endothelium, but repeated administration of heparin depletes vascular stores of TFPI. We studied the anticoagulant effects of unfractionated heparin (UFH) vs low‐molecular‐weight enoxaparin—used for thrice‐weekly maintenance haemodialysis (HD)—on plasma levels of total TF and TFPI and on those of an activated coagulation marker prothrombin fragment 1+2 (PF 1+2). Methods. Twenty‐five patients dialysed using a single injection of enoxaparin (at a mean dose of 0.68 mg/kg) were randomly assigned to either receive UFH administered as a mean bolus of 42.1 IU/kg and continuous infusion of 57.8 IU/kg (n=12) or to be maintained on enoxaparin (n=13), and were followed prospectively for 12 weeks. Plasma immunoreactive TF, TFPI and PF 1+2 were measured at the start and after 10 and 180 min of HD, and compared with values in 15 healthy controls. Results. Pre‐dialysis TF, TFPI and PF 1+2 were higher than normal (all P<0.0001). TF and PF 1+2 did not change, while TFPI levels, compared with baseline, increased at each interval in enoxaparin‐anticoagulated HD patients (all P<0.0001). TFPI increments correlated inversely with pre‐dialysis TFPI (both P<0.0007). In patients switched to UFH, TF levels remained unchanged compared with pre‐randomization values, TFPI increased at each interval of HD sessions (all P<0.035) and PF 1+2 increased pre‐dialysis (P=0.015). The over‐dialysis effects of UFH resembled those of enoxaparin. In contrast, baseline TFPI and its 10‐min rise correlated inversely with the UFH loading dose (both P<0.040). Pre‐dialysis PF 1+2 was inversely associated with TFPI increments (both P<0.034), and directly with pre‐dialysis TFPI (P=0.018) and the UFH loading dose (P=0.045). Conclusions. Depletion of heparin‐releasable stores of TFPI is an untoward effect of repeated anticoagulation during maintenance HD therapy. The traditional UFH regimen is more prothrombotic than single enoxaparin injections, with high loading doses of UFH being involved in TFPI exhaustion and subsequent hypercoagulability.

1 December 2003 in Kidney International
Verified
Journal Article
Closed access
JBJacek Borawski
Jacek Borawski
Beata NaumnikBeata Naumnik
Beata Naumnik
MMMichał Myśliwiec
Michał Myśliwiec
MIMicha
Micha